PV pharm branch, vendor, cage 0U9U0
Ended Awarded Last action
- Contract number
- SPE2D826FCR64
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $392,561
Award facts
- Contract value 100% obligated
- $392,561.31 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, issued on January 24, 2026, awards AmerisourceBergen Drug Corp (a subsidiary of parent company Cencora, Inc.) a firm fixed-price contract valued at $392,561.31 for pharmaceutical and medical supply delivery through January 26, 2026. The contract is funded by the Defense Logistics Agency's Medical Supply Chain division and carries no set-aside designation, indicating it was competitively awarded. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under a larger Indefinite Delivery Contract vehicle with the DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support program enabling the contractor to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide.
AmerisourceBergen has demonstrated significant capability in fulfilling federal medical procurement requirements through its extensive portfolio of pharmaceutical deliveries to military and veteran healthcare systems. The company's contract awards consistently involve firm fixed-price structures and cover diverse therapeutic domains including specialty medications, brand-name and generic drugs, diabetes treatments, neurological medications, pain management pharmaceuticals, and medical supplies such as auto-injectors and test kits. The DLA Medical Supply Chain has indicated plans to establish additional Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning AmerisourceBergen among the key suppliers for Defense Health Agency, U.S. Coast Guard, and other federal healthcare system customers.
Quick answers
Who was awarded contract SPE2D826FCR64?
SPE2D826FCR64 was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on January 24, 2026.
How much is contract SPE2D826FCR64 worth?
The government has obligated $392,561 on SPE2D826FCR64.
Is contract SPE2D826FCR64 an order under another contract?
Yes. SPE2D826FCR64 is a delivery order under SPE2DX22D0010, an indefinite delivery contract.
Was contract SPE2D826FCR64 competed?
The extent of competition for SPE2D826FCR64 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award